OLFC Announced that Its Manufacturing Partner, FFS, has Kosher Certification

PHILADELPHIA, PA / ACCESSWIRE / March 27, 2015 / Olfactory Biosciences Corp (PINKSHEETS:OLFC) is pleased to announce that its manufacturing partner FFS has Kosher Certification as well as an FDA approved facility. FFS has the superior technical expertise that is necessary to produce our products. We recognize that the combined talent and enthusiasm of FFS employees is one of our most valuable resources.

The New 22nd Century Medicines from OLFC use natural ingredients, advanced Olfaction and chemoreception. Applying the new topical, non-prescription medicines is just rubbing a small amount of the balm to the end of your nostrils. https://noxoinfo.com

Olfactory receptors are nerves and neurotransmitters and act by attaching to the company’s natural ingredients, dependent on what the issue is to be solved. No aromatherapy or any known medical therapy or science is used. Olfactory Biosciences uses a new innovative delivery system, the company’s science and the science of the NOBEL Prize winners in Medicine 2004.

The lineup of the new advanced innovative topical medicines are below and are presented at https://noxoinfo.com

1. HungerMgmt(TM) Provides hours of relief from cravings and overeating.

2. Sensopath(TM) Offers relief from sensory issues and challenges that have the potential to trigger coping responses.

3. Exanstres(TM) Less stress and stress related symptoms in your life.

4.Somaklin(TM) Less anxiety, from a natural solution. Gain more calm and control.

5.Sambigan(TM) A great, natural night’s sleep.

6. Nootravate (TM) A great, natural way to improve your memory and increase your power to recall data, information and stored memories.

7. Studibuddy(TM) Avoid the dangerous trend of taking chemical drugs and excel with natural help and memory enhancement.

8. Emoodal(TM) Makes people feel in the best Mood in a calm-energy state.

9.NOXO Odor Defense Pro(TM) A great, natural way to relieve the distress and symptoms associated with noxious odors.

For more information and Ingredients, go to https://noxoinfo.com.

About Olfactory Biosciences Corp.

Olfactory Biosciences Corp. develops products targeting olfactory receptors in the nose for the desired effect. These topical non-prescription medicine products can modify behavior or provide relief to common behavior challenges such as anxiety, sensory issues or help with weight control. https://noxoinfo.com

FORWARD-LOOKING STATEMENTS

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company’s business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company’s products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company’s Securities and Exchange Commission (SEC) filings under “risk factors” and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Contact:

Richard Stevenson, President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Phone: 484-278-1626
Website: https://noxoinfo.com
E-mail: support@noxoinfo.com

SOURCE: Olfactory Biosciences Corp.

ReleaseID: 427274